In March 2025, the company introduced new options for the direct-to-purchaser supplying of its Wegovy weight loss drug. The company set up a new pharmacy, termed NovoCare, which would charge prospects $499 monthly for use of the drug, lower than half the price of the drug by means of other pharmaceutical distribution networks.[53]In October 2024, N